Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Pacific Biosciences (PACB)

Pacific Biosciences (PACB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 714,347
  • Shares Outstanding, K 152,965
  • Annual Sales, $ 78,630 K
  • Annual Income, $ -102,560 K
  • 60-Month Beta 1.68
  • Price/Sales 9.18
  • Price/Cash Flow N/A
  • Price/Book 9.81

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.16
  • Number of Estimates 2
  • High Estimate -0.14
  • Low Estimate -0.17
  • Prior Year -0.21
  • Growth Rate Est. (year over year) +23.81%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.37 +6.86%
on 11/08/19
5.53 -15.55%
on 10/21/19
-0.72 (-13.36%)
since 10/15/19
3-Month
4.37 +6.86%
on 11/08/19
5.94 -21.38%
on 08/19/19
-0.93 (-16.61%)
since 08/15/19
52-Week
4.37 +6.86%
on 11/08/19
7.84 -40.43%
on 11/30/18
-2.94 (-38.63%)
since 11/15/18

Most Recent Stories

More News
Pacific Bioscien Set to Possibly Pullback After Yesterday's Rally of 3.98%

Pacific Bioscien (NASDAQ:PACB) traded in a range yesterday that spanned from a low of $4.68 to a high of $4.82. Yesterday, the shares gained 4.0%, which took the trading range above the 3-day high of...

PACB : 4.67 (-1.06%)
Pacific Biosciences of California (PACB) Reports Q3 Loss, Misses Revenue Estimates

Pacific Biosciences (PACB) delivered earnings and revenue surprises of -26.67% and -21.80%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?...

PACB : 4.67 (-1.06%)
Pacific Biosciences: 3Q Earnings Snapshot

MENLO PARK, Calif. (AP) _ Pacific Biosciences of California Inc. (PACB) on Thursday reported a loss of $29.1 million in its third quarter.

PACB : 4.67 (-1.06%)
Pacific Biosciences of California, Inc. Announces Third Quarter 2019 Financial Results

Pacific Biosciences of California, Inc. (NASDAQ: PACB) (the "Company') today announced financial results for its third quarter ended September 30, 2019.

PACB : 4.67 (-1.06%)
Highly Accurate SMRT Sequencing for Human Genetics to Be Showcased at ASHG 2019 Annual Meeting

Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that more than 50 presentations will include...

PACB : 4.67 (-1.06%)
Downtrend Call Working As Pacific Bioscien Stock Falls 6.5% (PACB)

SmarTrend identified a Downtrend for Pacific Bioscien (NASDAQ:PACB) on July 19th, 2019 at $5.44. In approximately 3 months, Pacific Bioscien has returned 6.53% as of today's recent price of $5.08.

PACB : 4.67 (-1.06%)
Watch for Pacific Bioscien to Potentially Rebound After Falling 2.05% Yesterday

Pacific Bioscien (NASDAQ:PACB) traded in a range yesterday that spanned from a low of $4.96 to a high of $5.22. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $5.03...

PACB : 4.67 (-1.06%)
PGI Files Patent Infringement Complaint Against PacBio

Personal Genomics Taiwan, Inc. ("PGI"), today announced that it has filed a complaint in the U.S. District Court for the District of Delaware against Pacific Biosciences of California, Inc. ("PacBio")....

PACB : 4.67 (-1.06%)
Shares of Pacific Bioscien Rank the Highest in Terms of Relative Performance in the Life Sciences Tools & Services Industry (PACB , FLDM , CRL , BRKR , ILMN )

Here are the top 5 stocks in the Life Sciences Tools & Services industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were...

CRL : 139.07 (+1.08%)
FLDM : 2.51 (+1.62%)
PACB : 4.67 (-1.06%)
Here's Why You Should Retain Pacific Biosciences For Now

Pacific Biosciences (PACB) continues to gain from innovative product portfolio and Sequel system. However, contraction in gross margin remains a woe.

PACB : 4.67 (-1.06%)
BAX : 81.44 (+0.87%)
AMED : 152.85 (+1.05%)
CNMD : 112.99 (+0.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade PACB with:

Business Summary

Pacific Biosciences of California, Inc. is engaged in the development, manufacture and commercialization of its single molecule, real-time, or SMRT technology-an integrated platform for genetic analysis. The SMRT technology uses the natural processing power of enzymes, combined with specially designed...

See More

Key Turning Points

2nd Resistance Point 4.78
1st Resistance Point 4.72
Last Price 4.67
1st Support Level 4.64
2nd Support Level 4.62

See More

52-Week High 7.84
Fibonacci 61.8% 6.51
Fibonacci 50% 6.11
Fibonacci 38.2% 5.70
Last Price 4.67
52-Week Low 4.37

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar